SE8402938D0 - Cellyteproteiner; forfarande for deras framstellning samt anvendning av sa erhallna cellyteproteiner - Google Patents

Cellyteproteiner; forfarande for deras framstellning samt anvendning av sa erhallna cellyteproteiner

Info

Publication number
SE8402938D0
SE8402938D0 SE8402938A SE8402938A SE8402938D0 SE 8402938 D0 SE8402938 D0 SE 8402938D0 SE 8402938 A SE8402938 A SE 8402938A SE 8402938 A SE8402938 A SE 8402938A SE 8402938 D0 SE8402938 D0 SE 8402938D0
Authority
SE
Sweden
Prior art keywords
proteins
cell surface
production
cellyte
recalled
Prior art date
Application number
SE8402938A
Other languages
English (en)
Other versions
SE8402938L (sv
SE454403B (sv
Inventor
Magnus Hoeoek
Martin Kjell Lindberg
Torkel Mikael Wadstroem
Original Assignee
Magnus Hoeoek
Martin Kjell Lindberg
Torkel Mikael Wadstroem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magnus Hoeoek, Martin Kjell Lindberg, Torkel Mikael Wadstroem filed Critical Magnus Hoeoek
Priority to SE8402938A priority Critical patent/SE454403B/sv
Publication of SE8402938D0 publication Critical patent/SE8402938D0/sv
Priority to ES543635A priority patent/ES8900019A1/es
Priority to CA000482662A priority patent/CA1340401C/en
Priority to IE133785A priority patent/IE59203B1/en
Priority to NZ212244A priority patent/NZ212244A/xx
Priority to DE8585850190T priority patent/DE3577579D1/de
Priority to PCT/SE1985/000227 priority patent/WO1985005553A1/en
Priority to EP85850190A priority patent/EP0163623B1/en
Priority to AT85850190T priority patent/ATE52543T1/de
Priority to JP60502661A priority patent/JPH0747541B2/ja
Priority to AU44331/85A priority patent/AU600886B2/en
Publication of SE8402938L publication Critical patent/SE8402938L/sv
Priority to FI860417A priority patent/FI84431C/sv
Priority to NO86860321A priority patent/NO164992C/no
Publication of SE454403B publication Critical patent/SE454403B/sv
Priority to US07/801,593 priority patent/US5189015A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
SE8402938A 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel SE454403B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
ES543635A ES8900019A1 (es) 1984-05-30 1985-05-29 Un procedimiento para fabricar una proteina de la superficiede las celulas
CA000482662A CA1340401C (en) 1984-05-30 1985-05-29 Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained
IE133785A IE59203B1 (en) 1984-05-30 1985-05-29 The use of a cell surface protein obtained from staph.aureus
NZ212244A NZ212244A (en) 1984-05-30 1985-05-29 Preparation of cell surface protein of fibronectin binding properties useful as topical anti-infectant and vaccine
AU44331/85A AU600886B2 (en) 1984-05-30 1985-05-30 Fibronectin-binding protein
PCT/SE1985/000227 WO1985005553A1 (en) 1984-05-30 1985-05-30 Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and profylactic treatment
DE8585850190T DE3577579D1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
EP85850190A EP0163623B1 (en) 1984-05-30 1985-05-30 The use of a cell surface protein obtained from staph. aureus
AT85850190T ATE52543T1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
JP60502661A JPH0747541B2 (ja) 1984-05-30 1985-05-30 細胞表面蛋白質とその製法及びその使用法
FI860417A FI84431C (sv) 1984-05-30 1986-01-29 Förfarande för framställning av ett fibronektinbindande cellyteprotein
NO86860321A NO164992C (no) 1984-05-30 1986-01-29 Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper.
US07/801,593 US5189015A (en) 1984-05-30 1991-12-05 Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Publications (3)

Publication Number Publication Date
SE8402938D0 true SE8402938D0 (sv) 1984-05-30
SE8402938L SE8402938L (sv) 1985-12-01
SE454403B SE454403B (sv) 1988-05-02

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Country Status (13)

Country Link
EP (1) EP0163623B1 (sv)
JP (1) JPH0747541B2 (sv)
AT (1) ATE52543T1 (sv)
AU (1) AU600886B2 (sv)
CA (1) CA1340401C (sv)
DE (1) DE3577579D1 (sv)
ES (1) ES8900019A1 (sv)
FI (1) FI84431C (sv)
IE (1) IE59203B1 (sv)
NO (1) NO164992C (sv)
NZ (1) NZ212244A (sv)
SE (1) SE454403B (sv)
WO (1) WO1985005553A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
EP0621875B1 (en) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen binding protein
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EP2548884B1 (en) 2005-08-10 2017-08-02 Arne Forsgren AB Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
JP5395264B2 (ja) 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
JPS61502334A (ja) 1986-10-16
ES8900019A1 (es) 1988-11-01
EP0163623A2 (en) 1985-12-04
AU600886B2 (en) 1990-08-30
SE8402938L (sv) 1985-12-01
NZ212244A (en) 1989-03-29
NO164992C (no) 1990-12-05
FI84431C (sv) 1991-12-10
SE454403B (sv) 1988-05-02
IE59203B1 (en) 1994-01-26
JPH0747541B2 (ja) 1995-05-24
FI860417A0 (fi) 1986-01-29
DE3577579D1 (de) 1990-06-13
WO1985005553A1 (en) 1985-12-19
ATE52543T1 (de) 1990-05-15
FI860417A (fi) 1986-01-29
ES543635A0 (es) 1988-11-01
NO164992B (no) 1990-08-27
EP0163623B1 (en) 1990-05-09
CA1340401C (en) 1999-02-23
FI84431B (fi) 1991-08-30
NO860321L (no) 1986-01-29
EP0163623A3 (en) 1987-02-25
IE851337L (en) 1985-11-30

Similar Documents

Publication Publication Date Title
SE8402938D0 (sv) Cellyteproteiner; forfarande for deras framstellning samt anvendning av sa erhallna cellyteproteiner
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
ATE130031T1 (de) Verwendungen viraler enzyme.
SE8801701D0 (sv) Production technology based on enzymic method
DE3789428D1 (de) Mikroorganismen, fähig zur Laktoseassimilation.
DE3688740D1 (de) Verfahren zur veraetherung von galaktomannanen.
DE3789309D1 (de) Enzymatische membran, verfahren zur herstellung und trennung von peptiden.
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
DE69010268D1 (de) Isolierungsmedium zur Identifizierung der Salmonella-Bakterien.
ES2018734A6 (es) Procedimiento para la obtencion de un enzima proteolitico.
DK442289A (da) Fremgangsmaade til forhoejelse af enzymaktiviteter og synteseeffekt hos organismer
SU731935A1 (ru) Способ разрушени клеточной оболочки хлореллы
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
AU7293387A (en) Process for the treatment of milk for cheesemaking
SE8003630L (sv) Forfarande for framstellning av d-alfa-aminosyror
EP0302459A3 (en) Human placenta-derived thermostable cell growth factor and a process for production thereof
ATE77831T1 (de) Verfahren zur gewinnung von insektenpathogenen proteinen und mikroorganismen des typs bacillus thuringiensis.
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
SE8506080D0 (sv) Ligninjesning under transport
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
ATE56988T1 (de) Verfahren zur submersen zuechtung von pseudomonas aeruginosa-bakterienstaemmen.
ATE46308T1 (de) Vorrichtung zur vernichtung von mikroorganismen.
DD136268A1 (de) Methode zur isolierung von proteinen und enzymen

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8402938-8

Format of ref document f/p: F

NUG Patent has lapsed